Company Overview and News

1
Is iShares Edge MSCI Multifactor Intl ETF (INTF) a Hot ETF Right Now?

2018-10-11 zacks
Designed to provide broad exposure to the Broad Developed World ETFs category of the market, the iShares Edge MSCI Multifactor Intl ETF (INTF - Free Report) is a smart beta exchange traded fund launched on 04/28/2015.
AXAHF VEA AXAHY 6501 VEU CS AXJ HTHIY

 
Fmr. AllianceBernstein CEO has a message for managers at his new firm: Perform, or take a pay cut

2018-09-20 cnbc
His new venture, Aperture Investors, is paying fund managers based on how they perform against the broader market, and will only charge higher fees than exchange-traded funds when they beat the market, according to a Wall Street Journal report.
AXAHF AXAHY CS AXJ

23
Apollo to buy Aspen for US$2.6 bil in insurance expansion

2018-08-28 theedgemarkets
(Aug 28): Apollo Global Management LLC, the investment firm led by Leon Black, agreed to acquire Aspen Insurance Holdings Ltd for US$2.6 billion, in the latest example of private equity investors expanding their insurance assets.
BGX AXAHF ESUR ATH CS CG BGLF BX AXJ APO BGB AXAHY ESXRY AHL

1
AXA (AXAHF) CEO Thomas Buberl on Q2 2018 Results - Earnings Call Transcript

2018-08-06 seekingalpha
Okay, well good afternoon everyone and welcome to Axis 2018 Half Year Results. A very warm literally welcome to those in the room, welcome to those on the telephone, welcome to those on the webcast and again very warm welcome to those here in London.
AXAHF AXAHY SCGLF CS EQH SCGLY XL XLGLF GLE AXJ

5
MOVES-DWS adds executives to institutional client team

2018-07-19 reuters
(Reuters) - Asset manager DWS Group GmbH & Co (DWSG.DE) said it made three senior appointments to its institutional client team across Europe.
AXAHF C CS AXJ AXAHY BLK CGBBW

2
Banks Pivot Toward Greener Finance in Climate Action Push - Bloomberg

2018-07-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
AXAHF AXAHY NTXFF UBS CS KN NTXFY AXJ ULSGF

12
Ex-State Street executive convicted in U.S. of hidden fee fraud | Reuters

2018-06-26 reuters
BOSTON (Reuters) - A former State Street Corp (STT.N) executive was convicted on Tuesday of participating in a scheme to defraud several of the bank’s customers by charging them secret commissions on billions of dollars of trades.
STT AXAHF AXAHY CS AXJ

12
Ex-State Street exec pulled 'bait-and-switch' on clients: US prosecutor

2018-06-25 channelnewsasia
A former State Street Corp executive engaged in "bait-and switch" by promising to charge several of the bank's clients low fees to execute billions of dollars of trades before secretly applying commissions to them, a U.S. prosecutor said on Monday.
STT AXAHF AXAHY CS AXJ

12
Ex-State Street exec pulled 'bait-and-switch' on clients -U.S. prosecutor

2018-06-25 reuters
BOSTON (Reuters) - A former State Street Corp (STT.N) executive engaged in “bait-and switch” by promising to charge several of the bank’s clients low fees to execute billions of dollars of trades before secretly applying commissions to them, a U.S. prosecutor said on Monday.
STT AXAHF AXAHY CS AXJ

1
AXA Equitable Holdings (EQH) CEO Mark Pearson on Q1 2018 Results - Earnings Call Transcript

2018-06-20 seekingalpha
Good morning. My name is Mitchell and I will be your conference operator today. At this time, I would like to welcome everyone to the AXA Equitable Holdings Inc. First Quarter 2018 Results. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions].
AXAHF AXAHY CS EQH DTK AXJ

176
Allianz’s deal hunt keeps mart guessing

2018-06-12 bworldonline
Europe’s largest insurer, Allianz SE, is in the early stages of evaluating a variety of potential acquisition targets as deal-hungry Chief Executive Officer Oliver Baete scans the market for growth, people with knowledge of the matter said. Those on the list range from Switzerland’s Zurich Insurance Group AG and the UK’s RSA Insurance Group Plc to Hartford Financial Services Group Inc. in the US or, going further afield, assets in China, they said.
VR ALIZF AXJ QBIEY ARGO HGH 8685 ZFSVF AVF AIG QBEIF ZURVY CGBBW AHL RSAB XLGLF AXAHF NRDEF CS XL AXAHY UBS HIG RSAIF NRBAY AZSEY RSA AGIIL C AGII QBE RSNAY ULSGF

12
Ex-State Street executive cheated clients with secret fees: U.S. prosecutor

2018-06-05 reuters
BOSTON (Reuters) - A former State Street Corp (STT.N) executive directed a fraudulent scheme to overcharge several of the bank’s clients, including Kuwait’s sovereign wealth fund, by applying secret commissions to billions of dollars’ worth of trades, a U.S. prosecutor told jurors on Tuesday.
STT AXAHF AXAHY CS AXJ

12
Ex-State Street executive cheated clients with secret fees: US prosecutor - Channel NewsAsia

2018-06-05 channelnewsasia
A former State Street Corp executive directed a fraudulent scheme to overcharge several of the bank's clients, including Kuwait's sovereign wealth fund, by applying secret commissions to billions of dollars' worth of trades, a U.S. prosecutor told jurors on Tuesday.
STT AXAHF AXAHY CS AXJ

12
Ex-State Street executive cheated clients with secret fees: U.S. prosecutor

2018-06-05 reuters
BOSTON, June 5 (Reuters) - A former State Street Corp executive directed a fraudulent scheme to overcharge several of the bank’s clients, including Kuwait’s sovereign wealth fund, by applying secret commissions to billions of dollars’ worth of trades, a U.S. prosecutor told jurors on Tuesday.
STT AXAHF AXAHY CS AXJ

2
Is iShares Edge MSCI Multifactor Intl ETF (INTF) a Hot ETF Right Now?

2018-05-17 zacks
The iShares Edge MSCI Multifactor Intl ETF (INTF - Free Report) made its debut on 04/28/2015, and is a smart beta exchange traded fund that provides broad exposure to the Broad Developed World ETFs category of the U.S. equity market.
AXAHF VEA AXAHY 6501 VEU CS AXJ HTHIY

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to EPA:CS / AXA on message board site Silicon Investor.

Politics for Conservatives Politics for Conservatives Politics for Conservatives Mainstream Politics and Economics Mainstream Politics and Economics Mainstream Politics and Economics
Severe weather events, climate change and economics Severe weather events, climate change and economics Severe weather events, climate change and economics Politics for Pros- moderated Politics for Pros- moderated Politics for Pros- moderated
Robotics and Artificial Intelligence Robotics and Artificial Intelligence Robotics and Artificial Intelligence Hurricanes: Tracking and Economics Hurricanes: Tracking and Economics Hurricanes: Tracking and Economics
Immunomedics (IMMU) - moderated Immunomedics (IMMU) - moderated Immunomedics (IMMU) - moderated Politics of Energy Politics of Energy Politics of Energy
Plastics to Oil - Pyrolysis and Secret Catalysts and Alterna Plastics to Oil - Pyrolysis and Secret Catalysts and Alterna Plastics to Oil - Pyrolysis and Secret Catalysts and Alterna Politics - Left, Right and Center Politics - Left, Right and Center Politics - Left, Right and Center